Table 2.
Descriptive outcomes assessment for patients diagnosed with RSV
| Hospitalized high-riska | Hospitalized non-high-risk | |
|---|---|---|
| N = 756 | N = 37 | |
| Length of stay during initial hospitalization, mean (SD) | 7.0 (10.7) | 5.5 (4.6) |
| 30-day readmission, N (%) | 154 (20.4%) | 6 (16.2%) |
| Patients who were discharged to SNF, N (%) | 187 (24.7%) | 5 (13.5%) |
| % of patients not in SNF prior to hospitalization | 133 (71.1%) | 4 (80.0%) |
| % of patients in SNF prior to hospitalization | 54 (28.9%) | 1 (20.0%) |
| Length of stay in skilled nursing facility, mean (SD) | 7.8 (32.2) | 5.1 (17.9) |
| All-cause mortality, N (%) | ||
| Within 30 days of RSV diagnosis | 101 (13.4%) | 3 (8.1%) |
| Within 90 days of RSV diagnosis | 178 (23.5%) | 3 (8.1%) |
| Within 180 days of RSV diagnosis | 221 (29.2%) | 4 (10.8%) |
| Death during inpatient stay, N (%) | ||
| Within 30 days of RSV diagnosis | 32 (4.2%) | 0 (0.0%) |
| Within 90 days of RSV diagnosis | 57 (7.5%) | 0 (0.0%) |
| Within 180 days of RSV diagnosis | 69 (9.1%) | 1 (2.7%) |
RSV respiratory syncytial virus, SD standard deviation, SNF skilled nursing facility
aSee “Methods” and “Patient Selection” for high-risk criteria